Effects of Pingtusan Compounds on the Expression of MMP and TIMP in Retroocular Fibroblasts after CD40L Stimulation
1.No.2 Endocrinology Ward,the First Affiliated Hospital of Henan University of CM,Zhengzhou 450002,China
2.Huiji District People's Hospital,Zhengzhou 450044,China
3.Henan Workstation,Hubei Chen's Academic School Heritage Studio of Gall Disease,National Administration of Traditional Chinese Medicine,Zhengzhou 450000,China
*Corresponding author:YAN Shuxun,Professor,Chief physician,Doctoral supervisor;E-mail:ysx982001@163.com
WAN Hong,CHEN Yalin,CUI Yaping, et al. Effects of Pingtusan Compounds on the Expression of MMP and TIMP in Retroocular Fibroblasts after CD40L Stimulation [J]. Chinese General Practice, 2019, 22(36): 4493-4498. DOI: 10.12114/j.issn.1007-9572.2019.00.734.
万红,陈亚琳,崔亚萍等. 平突散系列复方对CD40L刺激后人球后成纤维细胞的MMP和TIMP表达的影响[J]. 中国全科医学, 2019, 22(36): 4493-4498. DOI: 10.12114/j.issn.1007-9572.2019.00.734.
[1]WALL J R,SALVI M,BERNARD N F,et al.Thyroid-associated ophthalmopathy——a model for the association of organ-specific autoimmune disorders[J].Immunol Today,1991,12(5):150-153.DOI:10.1016/S0167-5699(05)80044-1.
[2]BURCH H B,WARTOFSKY L.Graves' ophthalmopathy:current concepts regarding pathogenesis and management[J].Endocr Rev,1993,14(6):747-793.DOI:10.1210/edrv-14-6-747.
[3]HEUFELDER A E,BAHN R S.Detection and localization of cytokine immunoreactivity in retro-ocular connective tissue in Graves' ophthalmopathy[J].Eur J Clin Invest,1993,23(1):10-17.DOI:10.1111/j.1365-2362.1993.tb00712.x.
[4]屠晓芳,张洪梅.甲状腺相关性眼病的评估方法及激素治疗进展[J].中国全科医学,2017,20(18):2294-2298.DOI:10.3969/j.issn.1007-9572.2017.04.y13.
TU X F,ZHANG H M.Assessment method of thyroid associated ophthalmopathy and its steroid treatment process[J].Chinese General Practice,2017,20(18):2294-2298.DOI:10.3969/j.issn.1007-9572.2017.04.y13.
[5]YAN S X,WANG Y.Inhibitory effects of triptolide on IFN-γ induced HLA-DR,ICAM-1,CD40 expression on retroocular fibroblasts derived from patients with Graves'ophthalmopathy[J].Clin Exp Ophthalmol,2006,34(3):265-271.
[6]李蓓,郑燕林.夏枯草、浙贝提取物对体外培养TAO眼眶成纤维细胞的影响[J].眼科研究,2009,27(7):577-581.
LI B,ZHENG Y L.The influence of Prunella and Fritillaria thunbergii's extract on cultured orbital fibroblasts of TAO-patients[J].Chin Ophthalmic Res,2009,27(7):577-581.
[7]燕树勋,王颖,陈如泉.养目平突汤含药血清对人眼球后成纤维细胞的影响[J].现代中西医结合杂志,2008,17(24):3747-3748,3855.
YAN S X,WANG Y,CHEN R Q.Effects of yangmupingtutang containing serum on cultured retroocular fibroblasts in patients with Graves ophthalmopathy[J].Mod J Integr Tradit Chin West Med,2008,17(24):3747-3748,3855.
[8]李允.中药复方对人眼球后成纤维细胞Th1/Th2细胞因子失衡的影响[D].郑州:河南中医学院,2015.
[9]叶新.泻火平突散对IFN-γ刺激后人球后成纤维细胞的影响[D].郑州:河南中医学院,2015.
[10]卫忠壮.活血平突散对IFN-γ刺激后人球后成纤维细胞的影响[D].郑州:河南中医药大学,2016.
WEI Z Z.0bservation of impact that the huoxue pingtu powder has on retrobulbar fibroblasts after stimulated by IFN-γ[D].Zhengzhou:Henan University of Chinese Medicine,2016.
[11]张燕利.中药复方对TAO患者RFs中信号转导通路的影响[D].郑州:河南中医药大学,2016.
ZHANG Y L.Effect of Chinese herbal compound on signal transductiom pathwaysof retroocular fibroblasts in patients with TAO[D].Zhengzhou:Henan University of Traditional Chinese Medicine,2016.
[12]BAHN R S.Graves'Ophthalmopathy[J].N Engl J Med,2010,362(8):726-738.DOI:10.1056/NEJMra0905750.
[13]BAHN R S,HEUFELDER A E.Retroocular fibroblasts:important effector cells in Graves' ophthalmopathy[J].Thyroid,1992,2(1):89-94.DOI:10.1089/thy.1992.2.89.
[14]CAO H J,WANG H S,ZHANG Y,et al.Activation of human orbital fifibroblasts through CD40 engagement results in a dramaticinduction of hyaluronan synthesis and prostaglandin Endoperoxide H Synthase-2 expression[J].J Biol Chem,1998,273(45):29615-29625.
[15]SEMPOWSKI G D,ROZENBLIT J,SMITH T J,et al.Human orbital fibroblasts are activated through CD40 to induce proinflammatory cytokine production[J].Am J Physiol,1998,274(3):C707-714.DOI:10.1152/ajpcell.1998.274.3.C707.
[16]HWANG C J,AFIFIYAN N,SAND D,et al.Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40:CD154 hyperinduces IL-6,IL-8,and MCP-1[J].Invest Ophthalmol Vis Sci,2009,50(5):2262-2268.DOI:10.1167/iovs.08-2328.
[17]李佳,刘丹.基质金属蛋白酶及其抑制剂与眼部疾病[J].辽宁医学院学报,2008,29(2):183-186.DOI:10.3969/j.issn.1674-0424.2008.02.041.
LI J,LIU D.MMP and its inhibitors and eye diseases[J].Journal of Liaoning Medical College,2008,29(2):183-186.DOI: 10.3969/j.issn.1674-0424.2008.02.041.
[18]周华祥,王万杰,周春阳,等.中医眼科对鹃眼凝睛的认识与治疗[J].四川中医,2006,24(12):19-21.
ZHOU H X,WANG W J,ZHOU C Y,et a1.Understanding and treatment of eyelid eyesight in traditional Chinese medicine ophthalmology[J].Sichuan Traditional Chinese Medicine,2006,24(12):19-21.
[19]王旭.浅论甲亢性眼病的中医辨治[J].四川中医,2003,21(12):11-12.
WANG X.Discussion on TCM differentiation and treatment of hyperthyroid eye disease[J].Sichuan Chinese Medicine,2003,21(12):11-12.
[20]封伟,吴敏,刘克冕.甲状腺相关性眼病的中医治疗进展[J].中国中医眼科杂志,2015,25(2):143-145.DOI:10.13444/j.cnki.zgzyykzz.2015.02.023.
FENG W,WU M,LIU K M.Progress of traditional Chinese medicine treatment on thyroid-associated ophthalmopathy[J].China J Chin Ophthalmol,2015,25(2):143-145.DOI:10.13444/j.cnki.zgzyykzz.2015.02.023.
[21]谢传钞,吴镇阳.耳背放血配合计刺治疗甲状腺相关性眼病临床观察[J].光明中医,2014,29(9):1942-1943.DOI:10.3969/j.issn.1003-8914.2014.09.078.
XIE C C,WU Z Y.Clinical observation on the treatment of thyroid-associated ophthalmopathy with blood in the back of the ear and stabbing[J].Guangming Journal of Chinese Medicine,2014,29(9):1942-1943.DOI:10.3969/j.issn.1003-8914.2014.09.078.